First Trust Capital Management’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

First Trust Capital Management’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-240,733	Closed	-$2.51M	–	230
2023 Q1	$2.51M	Buy	240,733 +225,000	+1,430%	+$2.33M	0.11%	164
2022 Q4	$160K	Hold	15,733	–	–	0.01%	337
2022 Q3	$158K	Buy	+15,733	New	+$158K	0.01%	435

First Trust Capital Management's LVAC Position: Q2 2023 in Review

First Trust Capital Management sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 240,733 shares — an estimated $2.51M sold.

First Trust Capital Management first reported a position in LVAC in Q3 2022 and held it in 3 quarters. The position peaked at $2.51M in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

First Trust Capital Management reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
First Trust Capital Management sold 240,733 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $2.51M.
First Trust Capital Management first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q3 2022 and held it in 3 quarters.
First Trust Capital Management's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $2.51M in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on First Trust Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.